沈阳、盘锦两地分别组织从业人员参加考试，严格按照国家职业标准规定的理论知识和技能要求， 采用全国统一开发的认定题库，以理论与实操相结合的方式组织考试。理论科目涵盖老年护理基础、急 救规范、法律法规等内容，实操环节则聚焦生活照料、基础护理、应急处置、心理疏导等实战技能，全 面检验从业者的专业素养，从专业理论储备到实际操作能力，对考生进行全方位、立体化评估。 盘锦于2021年6月启动职工长护险制度试点，目前护理服务人员达到3292人，对于促进就业、助力 康养产业发展起到了积极作用。此次认定考试精准对接长护险制度实施中的技能人才需求缺口，促进从 业人员提高就业技能、持证上岗，进一步推进长期护理技能人才队伍建设，强化长期照护规范化职业化 发展。 近日，长期照护师职业技能等级认定第二次省际联考在辽宁等20个省（区、市）同时开展，我省 180名考生通过考试，成为我省首批获得健康照护师（长期照护师）职业技能等级证书的从业人员。 考试通过人员将获得人力资源社会保障部认可的健康照护师（长期照护师）职业技能等级证书，纳 入本市长期护理险服务人员库，为参保的失能、半失能人员提供专业照护服务。通过职业技能等级认 定，从业人员实现"持 ...

Core Insights - Pacific Health Care Organization, Inc. reported total revenues of $1,586,984 for Q3 2025, an increase from $1,500,837 in Q3 2024, reflecting a growth of approximately 5.8% year-over-year [2] - The company achieved an income from operations of $205,037 in Q3 2025, up from $151,577 in Q3 2024, indicating a significant increase of about 35.2% [2] - Net income for Q3 2025 was $223,002 or $0.02 per share, compared to $174,863 or $0.01 per share in Q3 2024, representing a year-over-year increase of approximately 27.4% [3] Financial Performance - Net cash provided by operating activities for the nine months ended September 30, 2025, was $809,710, a substantial increase of $702,600 compared to $107,110 for the same period in 2024 [3] - Net cash used in investing activities rose to $665,443 for the nine months ended September 30, 2025, from $183,644 in the same period of 2024, primarily due to increased investments in US Treasury Bills [4] - The company reported net cash used in financing activities of $36,055 for the nine months ended September 30, 2025, contrasting with net cash provided of $70,610 in the same period of 2024, attributed to an insurance financing agreement that matured early in 2025 [5] Cash Position - The balance of cash and cash equivalents as of September 30, 2025, was $2,178,688, compared to $2,070,476 at the end of 2024, indicating a slight increase in liquidity [6] Company Overview - Pacific Health Care Organization, Inc. specializes in workers' compensation cost containment, aiming to reduce medical claims expenses while ensuring high-quality healthcare for injured employees [7] - The company offers a range of services including Health Care Organizations, Medical Provider Networks, medical case management, utilization review, medical bill review, and Medicare set-aside services, available as bundled or standalone solutions [7]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Distinct Healthcare Holdings Limited 卓正醫療控股有限公司 (the "Company") (A company incorporated in the Cayman Islands with ...

Core Insights - Sotera Health Company (SHC) reported revenue of $311.31 million for the quarter ended September 2025, reflecting a year-over-year increase of 9.1% [1] - Earnings per share (EPS) for the quarter was $0.26, up from $0.17 in the same quarter last year, indicating a positive trend in profitability [1] - The reported revenue exceeded the Zacks Consensus Estimate of $305.33 million by 1.96%, while the EPS surpassed the consensus estimate of $0.22 by 18.18% [1] Financial Performance Metrics - Sotera Health's Sterigenics segment generated net revenues of $192.85 million, exceeding the average estimate of $190.27 million by two analysts, marking a year-over-year increase of 9.8% [4] - The Nelson Labs segment reported net revenues of $55.66 million, which fell short of the estimated $57.98 million, representing a decline of 5% compared to the previous year [4] - Nordion's net revenues reached $62.81 million, surpassing the average estimate of $57.08 million, with a significant year-over-year increase of 22.4% [4] Stock Performance - Shares of Sotera Health have returned +2.4% over the past month, outperforming the Zacks S&P 500 composite's +2.1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

BOWIE, Md.--(BUSINESS WIRE)--Winners Honored at Inovalon's Annual Empower Conference With 2025 Impact Awards for Advancing Healthcare Economics and Outcomes. ...

Financial Data and Key Metrics Changes - The company reported a revenue of $4.47 billion, reflecting a 7% increase year-over-year and a 6% organic growth [20][21] - Adjusted EBITDA for the quarter was $616 million, up 3% year-over-year, resulting in an adjusted EBITDA margin of 13.8% [21][25] - Earnings per share (EPS) grew 4% to $3.05, supported by a lower share count [21][25] - Operating cash flow reached $711 million, with a free cash flow conversion ratio of 171% [25] Business Line Data and Key Metrics Changes - National security and digital revenues increased by 8% year-over-year, with 7% coming from organic growth, driven by contract awards and increased volumes [22] - Health and civil revenues rose by 6% year-over-year, with a record non-GAAP operating income margin of 25.7% [23] - Defense systems grew by 11% year-over-year, marking its seventh consecutive period of high single to low double-digit growth [24] Market Data and Key Metrics Changes - The company experienced a 27% sequential increase in funded backlog, indicating strong customer demand [16] - The energy infrastructure business has grown significantly, now representing over $600 million in annual revenues [9] Company Strategy and Development Direction - The company is focused on its North Star 2030 strategy, which includes growth pillars such as space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services [8][12] - The company is investing in AI and automation to enhance operational efficiency and customer outcomes [7][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the current government shutdown, noting that most programs remain unaffected [4][19] - The company raised its guidance for 2025, reaffirming revenue guidance of $17 billion to $17.25 billion and increasing EBITDA and EPS guidance [18][26] Other Important Information - The company repurchased $100 million worth of shares and accelerated the payoff of $450 million on its term loan [17] - A dividend of $0.43 per share was announced, marking a 7.5% increase [17] Q&A Session Summary Question: Thoughts on M&A in the current environment - Management indicated a shareholder-friendly approach to capital deployment, focusing on both organic growth and selective M&A opportunities [30][31] Question: Growth in defense systems segment - Management highlighted tracking 10 franchise programs expected to deliver about $15 billion in potential value over the next five years [36] Question: Sustainability of health and civil segment margins - Management expressed confidence in sustaining high margins through innovation and technology investments [45][49] Question: Bid expectations for next year - Management expects a significant increase in bid submissions next year, with a robust pipeline of $69 billion in near-term opportunities [55][58] Question: Impact of the government shutdown on Q4 - Management acknowledged potential risks from the shutdown but remained optimistic about returning to normal operations quickly [74][75] Question: International business performance - Management expressed confidence in growing the international business, particularly in Australia and the U.K., aligned with growth pillars [100] Question: Potential spin-off of Dynetics - Management emphasized the value of Dynetics within the Leidos portfolio and plans to invest in it rather than consider a spin-off [106][108] Question: Recompete contracts for next year - Management noted that it is too early to specify recompete contracts but highlighted several areas with growth momentum [90][92]

Core Insights - DocGo Inc. is launching Longitudinal Care Services in partnership with a California-based insurance provider, aiming to enhance its primary care capabilities [1] - The new program will focus on preventative care, chronic care management, and transitions of care services [1] - The target audience for this initiative includes 10,000 plan members who are currently under-engaged [1]

Core Insights - Sotera Health Company reported strong financial results for the third quarter and first nine months of 2025, with significant revenue and income growth compared to the previous year [2][3][4]. Financial Performance - Third-quarter 2025 net revenues increased by 9.1% to $311 million, up from $285 million in the third quarter of 2024. On a constant currency basis, the increase was 8.0% [2][8]. - Net income for the third quarter of 2025 was $48 million, or $0.17 per diluted share, compared to $17 million, or $0.06 per diluted share in the same quarter of 2024 [2][8]. - Adjusted EBITDA for the third quarter of 2025 rose by 12.2% to $164 million, with an 11.2% increase on a constant currency basis [2][8]. - For the first nine months of 2025, net revenues grew by 6.2% to $860 million, with net income of $43 million, or $0.15 per diluted share, compared to $32 million, or $0.11 per diluted share in the same period of 2024 [3][8]. Business Segment Performance - Sterigenics segment reported net revenues of $193 million for the third quarter of 2025, a 9.8% increase, with segment income rising by 11.6% to $107 million [5][6]. - Nordion's net revenues increased by 22.4% to $63 million in the third quarter of 2025, with segment income up by 19.9% to $38 million [9][10]. - Nelson Labs experienced a decrease in net revenues by 5.0% to $56 million in the third quarter of 2025, but segment income increased by 1.9% to $19 million [11][12]. Outlook and Guidance - The company reaffirmed its 2025 revenue outlook, projecting growth in the range of 4.5% to 6.0% on a constant currency basis, and raised its Adjusted EBITDA growth outlook to 6.75% to 7.75% [4][16]. - The interest expense range was improved to $154 million to $158 million, and the tax rate applicable to Adjusted Net Income was adjusted to 29.00% to 31.00% [16][17]. Balance Sheet and Liquidity - As of September 30, 2025, Sotera Health had total debt of $2.2 billion and unrestricted cash of $299 million, with a Net Leverage Ratio improved to 3.3x [13][14]. - The company achieved a contractual net leverage target, resulting in a 25 basis point reduction in the interest rate on its First Lien Term Loan facility [14].

Ritankar Das wants the holding company to make its comeback. “For the 20th century and for much of human history, [holding companies] were how things worked,” said Das, founder of AI-focused holding company Titan Holdings. “That’s how you got your railroads to work, in conjunction with other types of industries that were adjacent.” While such conglomerates exist today (like Koch Industries or Danaher), you don’t necessarily see new ones being formed, Das adds. However one feels about Koch or the “robber ...

Group 1 - Tenet Healthcare Corporation announced a private placement offering totaling $1.5 billion in senior secured first lien notes due November 15, 2032, with an interest rate of 5.500% per annum [1] - The company will also issue $0.75 billion in senior notes due November 15, 2033, which will bear an interest rate of 6.000% [1]